U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07904650) titled 'PRP Versus Saline Hydrodissection for CTS RCT' on Oct. 23.
Brief Summary: This single-center, single-blind, randomized controlled trial compared two injectates used for ultrasound-guided hydrodissection of the median nerve in adults with carpal tunnel syndrome: autologous platelet-rich plasma (PRP) and 0.9% normal saline (NS). Participants received a single hydrodissection with 5 mL of the allocated injectate per treated wrist; in participants with bilateral carpal tunnel syndrome, both wrists were treated with the same injectate. Symptom severity and functional status (Boston Carpal Tunnel Questionnaire), neuropathic pain (DN4 ques...